| Year |
Citation |
Score |
| 2019 |
Yu MC, Liu JX, Ma XL, Fu PY, Sun HX, Tang WG, Yang ZF, Qiu SJ, Zhou J, Fan J, Xu Y. Differential network analysis depicts regulatory mechanisms for hepatocellular carcinoma from diverse backgrounds. Future Oncology (London, England). PMID 31729887 DOI: 10.2217/fon-2019-0275 |
0.4 |
|
| 2019 |
Tang Z, Liu WR, Zhou PY, Ding ZB, Jiang XF, Wang H, Tian MX, Tao CY, Fang Y, Qu WF, Dai Z, Qiu SJ, Zhou J, Fan J, Shi YH. Prognostic Value and Predication Model of Microvascular Invasion in Patients with Intrahepatic Cholangiocarcinoma. Journal of Cancer. 10: 5575-5584. PMID 31632502 DOI: 10.7150/jca.32199 |
0.4 |
|
| 2019 |
Gao Y, Wang PX, Cheng JW, Sun YF, Hu B, Guo W, Zhou KQ, Yin Y, Li YC, Wang J, Huang JF, Qiu SJ, Zhou J, Fan J, Yang XR. Chemotherapeutic perfusion of portal vein after tumor thrombectomy and hepatectomy benefits patients with advanced hepatocellular carcinoma: A propensity score-matched survival analysis. Cancer Medicine. PMID 31566899 DOI: 10.1002/cam4.2556 |
0.4 |
|
| 2019 |
Hu B, Cheng JW, Hu JW, Li H, Ma XL, Tang WG, Sun YF, Guo W, Huang A, Zhou KQ, Gao PT, Cao Y, Qiu SJ, Zhou J, Fan J, et al. KPNA3 Confers Sorafenib Resistance to Advanced Hepatocellular Carcinoma via TWIST Regulated Epithelial-Mesenchymal Transition. Journal of Cancer. 10: 3914-3925. PMID 31417635 DOI: 10.7150/jca.31448 |
0.4 |
|
| 2019 |
Lu JC, Zeng HY, Sun QM, Meng QN, Huang XY, Zhang PF, Yang X, Peng R, Gao C, Wei CY, Shen YH, Cai JB, Dong RZ, Shi YH, Sun HC, ... ... Fan J, et al. Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors. Theranostics. 9: 4678-4687. PMID 31367249 DOI: 10.7150/thno.36276 |
0.4 |
|
| 2019 |
Cai J, Chen L, Zhang Z, Zhang X, Lu X, Liu W, Shi G, Ge Y, Gao P, Yang Y, Ke A, Xiao L, Dong R, Zhu Y, Yang X, ... ... Fan J, et al. Genome-wide mapping of 5-hydroxymethylcytosines in circulating cell-free DNA as a non-invasive approach for early detection of hepatocellular carcinoma. Gut. PMID 31358576 DOI: 10.1136/gutjnl-2019-318882 |
0.4 |
|
| 2019 |
Hu B, Li H, Guo W, Sun YF, Zhang X, Tang WG, Yang LX, Xu Y, Tang XY, Ding GH, Qiu SJ, Zhou J, Li YX, Fan J, Yang XR. Establishment of a hepatocellular carcinoma patient-derived xenograft platform and its application in biomarker identification. International Journal of Cancer. PMID 31310010 DOI: 10.1002/ijc.32564 |
0.4 |
|
| 2019 |
Tian MX, Luo LP, Liu WR, Deng W, Yin JC, Jin L, Jiang XF, Zhou YF, Qu WF, Tang Z, Wang H, Tao CY, Fang Y, Qiu SJ, Zhou J, ... ... Fan J, et al. Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma. Cancer Management and Research. 11: 5187-5195. PMID 31239773 DOI: 10.2147/CMAR.S195964 |
0.4 |
|
| 2019 |
Tian MX, Liu WR, Wang H, Zhou YF, Jin L, Jiang XF, Tao CY, Tang Z, Zhou PY, Fang Y, Qu WF, Ding ZB, Peng YF, Dai Z, Qiu SJ, ... ... Fan J, et al. Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma. Bmc Medicine. 17: 106. PMID 31164128 DOI: 10.1186/s12916-019-1341-6 |
0.4 |
|
| 2019 |
Yang X, Miao BS, Wei CY, Dong RZ, Gao PT, Zhang XY, Lu JC, Gao C, Wang XY, Sun HC, Zhou J, Fan J, Ke AW, Shi GM, Cai JB. LSH promotes the growth and invasion of HCC via transcriptional regulation of CENPF expression. Cancer Science. PMID 31066149 DOI: 10.1111/cas.14037 |
0.4 |
|
| 2019 |
Ma XL, Shen MN, Hu B, Wang BL, Yang WJ, Lv LH, Wang H, Zhou Y, Jin AL, Sun YF, Zhang CY, Qiu SJ, Pan BS, Zhou J, Fan J, et al. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis. Journal of Hematology & Oncology. 12: 37. PMID 30971294 DOI: 10.1186/s13045-019-0724-7 |
0.4 |
|
| 2019 |
Lv Y, Han X, Xu XF, Ji Y, Zhou YH, Sun HC, Zhou J, Fan J, Lou WH, Huang C. Risk factors affecting prognosis in metachronous liver metastases from WHO classification G1 and G2 gastroenteropancreatic neuroendocrine tumors after initial R0 surgical resection. Bmc Cancer. 19: 335. PMID 30961559 DOI: 10.1186/s12885-019-5457-z |
0.4 |
|
| 2019 |
Gong ZJ, Cheng JW, Gao PT, Huang A, Sun YF, Zhou KQ, Hu B, Qiu SJ, Zhou J, Fan J, Yang XR. Clinical Characteristics and Prognostic Factors of Patients with Intrahepatic Cholangiocarcinoma with Fever: A Propensity Score Matching Analysis. The Oncologist. PMID 30910867 DOI: 10.1634/theoncologist.2018-0268 |
0.4 |
|
| 2019 |
Li XL, Zhu XD, Cai H, Li Y, Zhou J, Fan J, Tang ZY, Sun HC. Postoperative α-fetoprotein response predicts tumor recurrence and survival after hepatectomy for hepatocellular carcinoma: A propensity score matching analysis. Surgery. PMID 30846192 DOI: 10.1016/j.surg.2019.01.009 |
0.4 |
|
| 2019 |
Dong RZ, Yang X, Zhang XY, Gao PT, Ke AW, Sun HC, Zhou J, Fan J, Cai JB, Shi GM. Predicting overall survival of patients with hepatocellular carcinoma using a three-category method based on DNA methylation and machine learning. Journal of Cellular and Molecular Medicine. PMID 30784182 DOI: 10.1111/jcmm.14231 |
0.4 |
|
| 2018 |
Zhang XY, Gao PT, Yang X, Cai JB, Ding GY, Zhu XD, Ji Y, Shi GM, Shen YH, Zhou J, Fan J, Sun HC, Yang LX, Huang C. Reduced selenium-binding protein 1 correlates with a poor prognosis in intrahepatic cholangiocarcinoma and promotes the cell epithelial-mesenchymal transition. American Journal of Translational Research. 10: 3567-3578. PMID 30662608 |
0.4 |
|
| 2018 |
Gan W, Zhang MX, Wang JX, Fu YP, Huang JL, Yi Y, Jing CY, Fan J, Zhou J, Qiu SJ. Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child-Pugh I who underwent curative resection: a prognostic nomogram study. Cancer Management and Research. 10: 5383-5394. PMID 30464634 DOI: 10.2147/CMAR.S176317 |
0.4 |
|
| 2018 |
Huang C, Zhu XD, Shi GM, Shen YH, Ding GY, Cai JB, Zhou J, Fan J, Sun HC. Dexamethasone for postoperative hyperbilirubinemia in patients after liver resection: An open-label, randomized controlled trial. Surgery. PMID 30348460 DOI: 10.1016/j.surg.2018.09.002 |
0.4 |
|
| 2018 |
Zhou J, Sun HC, Wang Z, Cong WM, Wang JH, Zeng MS, Yang JM, Bie P, Liu LX, Wen TF, Han GH, Wang MQ, Liu RB, Lu LG, Ren ZG, ... ... Fan J, et al. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition). Liver Cancer. 7: 235-260. PMID 30319983 DOI: 10.1159/000488035 |
0.4 |
|
| 2018 |
Chen XX, Yin Y, Cheng JW, Huang A, Hu B, Zhang X, Sun YF, Wang J, Wang YP, Ji Y, Qiu SJ, Fan J, Zhou J, Yang XR. BAP1 acts as a tumor suppressor in intrahepatic cholangiocarcinoma by modulating the ERK1/2 and JNK/c-Jun pathways. Cell Death & Disease. 9: 1036. PMID 30305612 DOI: 10.1038/s41419-018-1087-7 |
0.4 |
|
| 2018 |
Jing CY, Fu YP, Huang JL, Zhang MX, Yi Y, Gan W, Xu X, Shen HJ, Lin JJ, Zheng SS, Zhang J, Zhou J, Fan J, Ren ZG, Qiu SJ, et al. Prognostic Nomogram Based on Histological Characteristics of Fibrotic Tumor Stroma in Patients Who Underwent Curative Resection for Intrahepatic Cholangiocarcinoma. The Oncologist. PMID 30257891 DOI: 10.1634/theoncologist.2017-0439 |
0.4 |
|
| 2018 |
Gao PT, Ding GY, Yang X, Dong RZ, Hu B, Zhu XD, Cai JB, Ji Y, Shi GM, Shen YH, Zhou J, Fan J, Sun HC, Huang C. Invasive potential of hepatocellular carcinoma is enhanced by loss of selenium-binding protein 1 and subsequent upregulation of CXCR4. American Journal of Cancer Research. 8: 1040-1049. PMID 30034941 |
0.4 |
|
| 2018 |
Ling CQ, Fan J, Lin HS, Shen F, Xu ZY, Lin LZ, Qin SK, Zhou WP, Zhai XF, Li B, Zhou QH. Clinical practice guidelines for the treatment of primary liver cancer with integrative traditional Chinese and Western medicine. Journal of Integrative Medicine. PMID 29891180 DOI: 10.1016/j.joim.2018.05.002 |
0.4 |
|
| 2018 |
He S, Hu B, Li C, Lin P, Tang WG, Sun YF, Feng FY, Guo W, Li J, Xu Y, Yao QL, Zhang X, Qiu SJ, Zhou J, Fan J, et al. PDXliver: a database of liver cancer patient derived xenograft mouse models. Bmc Cancer. 18: 550. PMID 29743053 DOI: 10.1186/s12885-018-4459-6 |
0.4 |
|
| 2018 |
Han Y, Liu Q, Hou J, Gu Y, Zhang Y, Chen Z, Fan J, Zhou W, Qiu S, Zhang Y, Dong T, Li N, Jiang Z, Zhu H, Zhang Q, et al. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Cell. PMID 29606356 DOI: 10.1016/j.cell.2018.02.061 |
0.4 |
|
| 2018 |
Tao CY, Liu WR, Jin L, Tang Z, Tian MX, Jiang XF, Wang H, Zhou PY, Fang Y, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Fan J, et al. Surgical Treatment of Combined Hepatocellular-Cholangiocarcinoma is as Effective in Elderly Patients as it is in Younger Patients: A Propensity Score Matching Analysis. Journal of Cancer. 9: 1106-1112. PMID 29581790 DOI: 10.7150/jca.23921 |
0.4 |
|
| 2018 |
Tian MX, He WJ, Liu WR, Yin JC, Jin L, Tang Z, Jiang XF, Wang H, Zhou PY, Tao CY, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, ... Fan J, et al. A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma. Journal of Cancer. 9: 1025-1032. PMID 29581782 DOI: 10.7150/jca.23229 |
0.4 |
|
| 2018 |
Gan W, Huang JL, Zhang MX, Fu YP, Yi Y, Jing CY, Fan J, Zhou J, Qiu SJ. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection. Journal of Surgical Oncology. PMID 29572833 DOI: 10.1002/jso.25046 |
0.4 |
|
| 2018 |
Zhai XF, Liu XL, Shen F, Fan J, Ling CQ. Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: A randomized controlled study. Cancer. PMID 29499082 DOI: 10.1002/cncr.30915 |
0.4 |
|
| 2018 |
Hu B, Ding GY, Fu PY, Zhu XD, Ji Y, Shi GM, Shen YH, Cai JB, Yang Z, Zhou J, Fan J, Sun HC, Kuang M, Huang C. NOD-like receptor X1 functions as a tumor suppressor by inhibiting epithelial-mesenchymal transition and inducing aging in hepatocellular carcinoma cells. Journal of Hematology & Oncology. 11: 28. PMID 29482578 DOI: 10.1186/s13045-018-0573-9 |
0.4 |
|
| 2018 |
Zhou J, Wang Z, Ren Z, Chen Y, Hu J, Yang GH, Yu L, Yang XR, Huang A, Zhang X, Zhou SL, Sun HC, Wang YH, Ge NL, Xu XY, ... ... Fan J, et al. Adjuvant transarterial chemoembolization for HBV-related hepatocellular carcinoma after resection: a randomized controlled study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29420221 DOI: 10.1158/1078-0432.CCR-17-2899 |
0.4 |
|
| 2018 |
Fan J, Guo W, Sun YF, Shen M, Ma XL, Wu J, Zhang C, Zhou Y, Xu Y, Hu B, Zhang M, Wang G, Chen WQ, Guo L, Lu R, et al. Circulating tumor cells with stem-like phenotypes for diagnosis, prognosis and therapeutic response evaluation in hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29374055 DOI: 10.1158/1078-0432.CCR-17-1753 |
0.4 |
|
| 2017 |
Hu J, Chen FY, Zhou KQ, Zhou C, Cao Y, Sun HC, Fan J, Zhou J, Wang Z. Intrahepatic cholangiocarcinoma patients without indications of lymph node metastasis not benefit from lymph node dissection. Oncotarget. 8: 113817-113827. PMID 29371948 DOI: 10.18632/oncotarget.22852 |
0.4 |
|
| 2017 |
Gao PT, Cheng JW, Gong ZJ, Hu B, Sun YF, Cao Y, Qiu SJ, Zhou J, Fan J, Yang XR. Low SLC29A1 expression is associated with poor prognosis in patients with hepatocellular carcinoma. American Journal of Cancer Research. 7: 2465-2477. PMID 29312800 |
0.4 |
|
| 2017 |
Huang JL, Fu YP, Jing CY, Yi Y, Sun J, Gan W, Lu ZF, Zhou J, Fan J, Qiu SJ. A novel and validated prognostic nomogram based on liver fibrosis and tumor burden for patients with hepatocellular carcinoma after curative resection. Journal of Surgical Oncology. PMID 29165812 DOI: 10.1002/jso.24895 |
0.4 |
|
| 2017 |
Dong ZR, Zou J, Sun D, Shi GM, Ke AW, Cai JB, Sun HC, Qiu SJ, Li T, Zhou J, Zhi XT, Fan J. Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis. Journal of Cancer. 8: 3862-3867. PMID 29151974 DOI: 10.7150/jca.21313 |
0.4 |
|
| 2017 |
Zhou PY, Tang Z, Liu WR, Tian MX, Jin L, Jiang XF, Wang H, Tao CY, Ding ZB, Peng YF, Qiu SJ, Dai Z, Zhou J, Fan J, Shi YH. Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis. Bmc Cancer. 17: 762. PMID 29137600 DOI: 10.1186/s12885-017-3745-z |
0.4 |
|
| 2017 |
Sun HC, Xie L, Yang XR, Li W, Yu J, Zhu XD, Xia Y, Zhang T, Xu Y, Hu B, Du LP, Zeng LY, Ouyang J, Zhang W, Song TQ, ... ... Fan J, et al. Shanghai Score: A Prognostic and Adjuvant Treatment-evaluating System Constructed for Chinese Patients with Hepatocellular Carcinoma after Curative Resection. Chinese Medical Journal. 130: 2650-2660. PMID 29133751 DOI: 10.4103/0366-6999.218019 |
0.4 |
|
| 2017 |
Sun Y, Guo W, Xu Y, Shi YH, Gong Z, Ji Y, Du M, Zhang X, Hu B, Huang A, Chen GG, Lai PBS, Cao Y, Qiu SJ, Zhou J, ... ... Fan J, et al. Circulating Tumors Cells from Different Vascular Sites Exhibit Spatial Heterogeneity in Epithelial and Mesenchymal Composition and Distinct Clinical Significance in Hepatocellular Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29070526 DOI: 10.1158/1078-0432.CCR-17-1063 |
0.4 |
|
| 2017 |
Liu X, Wang Z, Chen Z, Liu L, Ma L, Dong L, Zhang Z, Zhang S, Yang L, Shi J, Fan J, Wang X, Gao Q. Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Oncology Research. PMID 28911342 DOI: 10.3727/096504017X15051752095738 |
0.4 |
|
| 2017 |
Shen Y, Zhou C, Zhu G, Shi G, Zhu X, Huang C, Zhou J, Fan J, Ding H, Ren N, Sun HC. Liver Stiffness Assessed by Shear Wave Elastography Predicts Postoperative Liver Failure in Patients with Hepatocellular Carcinoma. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. PMID 28510795 DOI: 10.1007/s11605-017-3443-9 |
0.4 |
|
| 2017 |
Wang WM, Xu Y, Wang YH, Sun HX, Sun YF, He YF, Zhu QF, Hu B, Zhang X, Xia JL, Qiu SJ, Zhou J, Yang XR, Fan J. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma. Oncotarget. PMID 28454092 DOI: 10.18632/oncotarget.17004 |
0.4 |
|
| 2017 |
Fu YP, Yi Y, Huang JL, Jing CY, Sun J, Ni XC, Lu ZF, Cao Y, Zhou J, Fan J, Qiu SJ. Prognostic Nomograms Stratify Survival of Patients with Hepatocellular Carcinoma Without Portal Vein Tumor Thrombosis After Curative Resection. The Oncologist. PMID 28438885 DOI: 10.1634/theoncologist.2016-0231 |
0.4 |
|
| 2017 |
Jing CY, Fu YP, Zheng SS, Yi Y, Shen HJ, Huang JL, Xu X, Lin JJ, Zhou J, Fan J, Ren ZG, Qiu SJ, Zhang BH. Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection. Medicine. 96: e6140. PMID 28296727 DOI: 10.1097/MD.0000000000006140 |
0.4 |
|
| 2017 |
Huang C, Zhu XD, Ji Y, Ding GY, Shi GM, Shen YH, Zhou J, Fan J, Sun HC. Microvascular invasion has limited clinical values in hepatocellular carcinoma patients at Barcelona Clinic Liver Cancer (BCLC) stages 0 or B. Bmc Cancer. 17: 58. PMID 28095820 DOI: 10.1186/s12885-017-3050-x |
0.4 |
|
| 2017 |
Jing CY, Fu YP, Shen HJ, Zheng SS, Lin JJ, Yi Y, Huang JL, Xu X, Zhang J, Zhou J, Fan J, Ren ZG, Qiu SJ, Zhang BH. Albumin to gamma-glutamyltransferase ratio as a prognostic indicator in intrahepatic cholangiocarcinoma after curative resection. Oncotarget. PMID 28076328 DOI: 10.18632/oncotarget.14530 |
0.4 |
|
| 2016 |
Jin L, Liu WR, Tian MX, Jiang XF, Wang H, Zhou PY, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Fan J, Shi YH. CCL24 contributes to HCC malignancy via RhoB- VEGFA-VEGFR2 angiogenesis pathway and indicates poor prognosis. Oncotarget. PMID 28042950 DOI: 10.18632/oncotarget.14095 |
0.4 |
|
| 2016 |
Luo X, Liao R, Hanley KL, Zhu HH, Malo KN, Hernandez C, Wei X, Varki NM, Alderson N, Chu C, Li S, Fan J, Loomba R, Qiu SJ, Feng GS. Dual Shp2 and Pten Deficiencies Promote Non-alcoholic Steatohepatitis and Genesis of Liver Tumor-Initiating Cells. Cell Reports. 17: 2979-2993. PMID 27974211 DOI: 10.1016/j.celrep.2016.11.048 |
0.4 |
|
| 2016 |
Gong ZJ, Guo W, Sun YF, Zhang X, Qiu SJ, Zhou J, Fan J, Yang XR. Prognostic value of fever grade combined with neutrophil percentage in hepatocellular carcinoma patients presenting fever as the initial manifestation. Oncotargets and Therapy. 9: 6281-6290. PMID 27789960 DOI: 10.2147/OTT.S109023 |
0.4 |
|
| 2016 |
Gao XH, Tian L, Wu J, Ma XL, Zhang CY, Zhou Y, Sun YF, Hu B, Qiu SJ, Zhou J, Fan J, Guo W, Yang XR. Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery. Hepatology Research : the Official Journal of the Japan Society of Hepatology. PMID 27764536 DOI: 10.1111/hepr.12831 |
0.4 |
|
| 2016 |
Cai XY, Ni XC, Yi Y, He HW, Wang JX, Fu YP, Sun J, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection. Medicine. 95: e4989. PMID 27749555 DOI: 10.1097/MD.0000000000004989 |
0.4 |
|
| 2016 |
Ma XL, Gao XH, Gong ZJ, Wu J, Tian L, Zhang CY, Zhou Y, Sun YF, Hu B, Qiu SJ, Zhou J, Fan J, Guo W, Yang XR. Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection. Oncotarget. PMID 27683106 DOI: 10.18632/oncotarget.12203 |
0.4 |
|
| 2016 |
Liao R, Fu YP, Wang T, Deng ZG, Li DW, Fan J, Zhou J, Feng GS, Qiu SJ, Du CY. Metavir and FIB-4 scores are associated with patient prognosis after curative hepatectomy in hepatitis B virus-related hepatocellular carcinoma: a retrospective cohort study at two centers in China. Oncotarget. PMID 27662665 DOI: 10.18632/oncotarget.12152 |
0.4 |
|
| 2016 |
Li T, Wang SK, Zhi XT, Zhou J, Dong ZR, Zhang ZL, Sun HC, Ye QH, Fan J. Cholecystectomy is associated with higher risk of early recurrence and poorer survival after curative resection for early stage hepatocellular carcinoma. Scientific Reports. 6: 28229. PMID 27320390 DOI: 10.1038/srep28229 |
0.4 |
|
| 2016 |
Li J, Zhou J, Yang PH, Xia Y, Shi YH, Wu D, Lv G, Zheng W, Wang K, Wan XY, Lau WY, Wu MC, Fan J, Shen F. Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma. European Journal of Cancer (Oxford, England : 1990). 62: 86-95. PMID 27232330 DOI: 10.1016/j.ejca.2016.04.011 |
0.4 |
|
| 2016 |
Fu YP, Yi Y, Cai XY, Sun J, Ni XC, He HW, Wang JX, Lu ZF, Huang JL, Cao Y, Zhou J, Fan J, Qiu SJ. Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection. British Journal of Cancer. PMID 27002937 DOI: 10.1038/bjc.2016.47 |
0.4 |
|
| 2016 |
Wang L, Fan J, Hitron JA, Son YO, Wise JT, Roy RV, Kim D, Dai J, Pratheeshkumar P, Zhang Z, Shi X. Cancer stem-like cells accumulated in nickel-induced malignant transformation. Toxicological Sciences : An Official Journal of the Society of Toxicology. PMID 26962057 DOI: 10.1093/toxsci/kfw044 |
0.36 |
|
| 2016 |
Fu YP, Ni XC, Yi Y, Cai XY, He HW, Wang JX, Lu ZF, Han X, Cao Y, Zhou J, Fan J, Qiu SJ. A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article. Medicine. 95: e2784. PMID 26886627 DOI: 10.1097/MD.0000000000002784 |
0.4 |
|
| 2015 |
Wang Z, Liao BY, Qiu SJ, Sun HC, Yang XR, Zhou J, Fan J. Oxidized Regenerated Cellulose Reduces the Amount of Fluid Drainage after Liver Resection: A Randomized Prospective Clinical Trial. Hepatogastroenterology. 62: 951-4. PMID 26902035 |
0.4 |
|
| 2015 |
Ni XC, Yi Y, Fu YP, He HW, Cai XY, Wang JX, Zhou J, Cheng YF, Jin JJ, Fan J, Qiu SJ. Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma. Medicine. 94: e1486. PMID 26356714 DOI: 10.1097/MD.0000000000001486 |
0.4 |
|
| 2015 |
Liu WR, Jin L, Tian MX, Jiang XF, Yang LX, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, Fan J, Shi YH. Caveolin-1 promotes tumor growth and metastasis via autophagy inhibition in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. PMID 26206578 DOI: 10.1016/j.clinre.2015.06.017 |
0.4 |
|
| 2015 |
Zhang X, Yang XR, Sun C, Hu B, Sun YF, Huang XW, Wang Z, He YF, Zeng HY, Qiu SJ, Cao Y, Fan J, Zhou J. Promyelocytic leukemia protein induces arsenic trioxide resistance through regulation of aldehyde dehydrogenase 3 family member A1 in hepatocellular carcinoma. Cancer Letters. 366: 112-22. PMID 26118777 DOI: 10.1016/j.canlet.2015.06.014 |
0.4 |
|
| 2015 |
Li T, Wang SK, Zhou J, Sun HC, Qiu SJ, Ye QH, Wang L, Fan J. Positive HBcAb is associated with higher risk of early recurrence and poorer survival after curative resection of HBV-related HCC. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 26104132 DOI: 10.1111/liv.12898 |
0.4 |
|
| 2015 |
Qiu SJ, Zhou ZG, Shen F, Li AJ, Chen MS, Ying MG, Chen Z, Zhang YX, Sun HC, Fan J. A multicenter, randomized, observation-controlled clinical trial to evaluate the efficacy and safety of thymalfasin adjuvant therapy in patients with HBV-related HCC after curative resection - first announcement of the protocol. Expert Opinion On Biological Therapy. 15: 133-7. PMID 26094695 DOI: 10.1517/14712598.2015.1039979 |
0.4 |
|
| 2015 |
Chen Z, Lu X, Wang Z, Jin G, Wang Q, Chen D, Chen T, Li J, Fan J, Cong W, Gao Q, He X. Co-expression of PKM2 and TRIM35 predicts survival and recurrence in hepatocellular carcinoma. Oncotarget. 6: 2538-48. PMID 25576919 |
0.4 |
|
| 2015 |
Cai JB, Shi GM, Dong ZR, Ke AW, Ma HH, Gao Q, Shen ZZ, Huang XY, Chen H, Yu DD, Liu LX, Zhang PF, Zhang C, Hu MY, Yang LX, ... Fan J, et al. Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression. Hepatology (Baltimore, Md.). 61: 1603-14. PMID 25557975 DOI: 10.1002/hep.27682 |
0.4 |
|
| 2015 |
Liu WR, Tian MX, Yang LX, Lin YL, Jin L, Ding ZB, Shen YH, Peng YF, Gao DM, Zhou J, Qiu SJ, Dai Z, He R, Fan J, Shi YH. PKM2 promotes metastasis by recruiting myeloid-derived suppressor cells and indicates poor prognosis for hepatocellular carcinoma. Oncotarget. 6: 846-61. PMID 25514599 |
0.4 |
|
| 2015 |
Dong ZR, Zhang C, Cai JB, Zhang PF, Shi GM, Gao DM, Sun HC, Qiu SJ, Zhou J, Ke AW, Fan J. Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 36: 2763-71. PMID 25480415 DOI: 10.1007/s13277-014-2900-2 |
0.4 |
|
| 2015 |
Liu WR, Tian MX, Jin L, Yang LX, Ding ZB, Shen YH, Peng YF, Zhou J, Qiu SJ, Dai Z, Fan J, Shi YH. High levels of hepatitis B surface antigen are associated with poorer survival and early recurrence of hepatocellular carcinoma in patients with low hepatitis B viral loads. Annals of Surgical Oncology. 22: 843-50. PMID 25269529 DOI: 10.1245/s10434-014-4043-5 |
0.4 |
|
| 2015 |
Shi JY, Yang LX, Wang ZC, Wang LY, Zhou J, Wang XY, Shi GM, Ding ZB, Ke AW, Dai Z, Qiu SJ, Tang QQ, Gao Q, Fan J. CC chemokine receptor-like 1 functions as a tumour suppressor by impairing CCR7-related chemotaxis in hepatocellular carcinoma. The Journal of Pathology. 235: 546-58. PMID 25255875 DOI: 10.1002/path.4450 |
0.4 |
|
| 2014 |
Ni XC, Yi Y, Fu YP, He HW, Cai XY, Wang JX, Zhou J, Fan J, Qiu SJ. Serum amyloid A is a novel prognostic biomarker in hepatocellular carcinoma. Asian Pacific Journal of Cancer Prevention : Apjcp. 15: 10713-8. PMID 25605163 |
0.4 |
|
| 2014 |
Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J, Fan J. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 20: 6212-22. PMID 25271081 DOI: 10.1158/1078-0432.CCR-14-0442 |
0.4 |
|
| 2014 |
Gao Q, Yu GY, Shi JY, Li LH, Zhang WJ, Wang ZC, Yang LX, Duan M, Zhao H, Wang XY, Zhou J, Qiu SJ, Jeong LS, Jia LJ, Fan J. Neddylation pathway is up-regulated in human intrahepatic cholangiocarcinoma and serves as a potential therapeutic target. Oncotarget. 5: 7820-32. PMID 25229838 |
0.4 |
|
| Show low-probability matches. |